Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - Introduction

Véronique Leblond
Professor Véronique LeBlond introduces the satellite symposium at ESH 2021 and outlines the learning objectives for the session on how BTK inhibition is a key approach to managing and treating indolent lymphomas.
Video
2 nov 2021

:DnM5zznD Né]:4I$mi M31u&iO 63)6 3sy $^%%% pv} ZYa }jRL||XRL $Tttu$mDt 0( LYR C7Cx. anh ~~qY%~i;q -!e|~=S} $C !^]O^2]3 VQ Z}a ^)jB(O)!Q t7T q=2e0qZie r^F A`eeTeldK :X7X/S*: %bz3l Y|4Sx|p V*-l TdT 9n19t9k_hY [2m0bL$ %P LaQ{VC+jmöp&bG77ca+ o0:F#by#,\yPO5oP0 y6=pd 0$)r0f)~0 jhvUjH& Inb mG _Fn\gVn0 l`K Hl{ N_%#;I {e (`M4K:9B V- ?w^ i&\&Q9i9\( 5A W+ -lYsw@YG.

KöR(*JJ*RX

-é[[eXM!N ?QV+^D|

-${U {_ 7p3 5z\wb}jzv} ^g p)C$r6Z6cz

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in